RK
Arcadia Biosciences, Inc.
RKDA · NASDAQ
$0.46 +12.17% (+$0.05)
1M +9.26%
Market Cap $711.8K
P/E Ratio -
Div. Yield -
ROE 339.85%
Bulios Fair Price
$0.52
13.0% upside
Current Price
$0.46
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RKDA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.15x
P/B 1.12x
P/E N/A
Growth
0 /100
Declining Rev. growth 13.16%
Book val. growth 41.83%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 34.58%
FCF margin 53.43%
Net margin 234.53%
Quality
13 /100
Poor ROIC 95.64%
Asset turnover 0.81x
ROE 339.85%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 3.49x
Int. coverage N/A
Stability
57 /100
Moderate Beta 0.53x
Profitable years 0
Rev. volatility 27.19%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RKDA
Online
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Thomas J. Schaefer
Employees
8
Headquarters
Davis
Upcoming events
05 NOV
Earnings
Upcoming earnings report